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Abstract
Purpose There are various options for treating periprosthetic
joint infection (PJI). Two-stage exchange has traditionally
been the gold standard. However, if the appropriate surgical
intervention is chosen according to a rational algorithm, the
outcome is similar when using all types of interventions. In an
observational cohort study, the outcome of patients with PJI
after hip replacement treated with one-stage revision was
analysed.
Methods All patients fulfilling all criteria for one-stage ex-
change according to the Infectious Diseases Society of
America (IDSA) guidelines and six without preoperative iden-
tification of a microorganism were included. Implant removal,
debridement and cemented or uncemented reimplantations
were performed in a single intervention. If a cemented device
was implanted, commercially available gentamicin cement
was used in all cases. Antibiotic treatment was administered
intravenously for at least 2 weeks, followed by oral therapy for
a total duration of 3 months. Patients had standardised clinical
and radiological follow-up visits.
Results Between 1996 and 2011, 38 patients (39 hips) were
treated with a one-stage procedure and followed for at least
2 years. Coagulase-negative staphylococci were the most fre-
quent pathogens, and polymicrobial infection was observed in
five cases. In 25 hips, an uncemented revision stem was im-
planted, and 37 hips received an acetabular reinforcement
ring. Themean follow-up was 6.6 (2.0–15.1) years. No patient
had persistent, recurrent or new infection. There were four
stem revisions for aseptic loosening. The mean Harris Hip
Score was 81 points (26–99) at the final follow-up.
Conclusions Excellent cure rate and function seen in our
study suggest that one-stage exchange is a safe procedure,
even without local antibiotic treatment, provided that the pa-
tient has no sinus tract or severe soft tissue damage, no major
bone grafting is required and the microorganism is susceptible
to orally administered agents with high bioavailability.
Keywords Hip arthroplasty . Infection . One-stage . Hip
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Introduction
Periprosthetic joint infection (PJI) is a major complication
after total joint replacement and causes additional surgery,
functional impairment and high medical costs. There is an
increasing incidence of PJI due to an increasing number
of operations and patients at risk living with orthopaedic
implants [1]. The diagnostic and therapeutic management
of PJI is demanding and expensive. Various treatment op-
tions are discussed controversially, and reported case se-
ries are difficult to compare with each other. Prospective
randomised trials are difficult or even impossible to
achieve, and therefore lacking [2].
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Two-stage exchange is an established and reliable treat-
ment strategy for infection eradication [3] but is a complex
and extensive surgical procedure. It requires at least two major
surgical interventions, may cause loss of function due to soft-
tissue and bone damage and is associated with considerable
mortality [2, 3]. One-stage exchange with the use of
antibiotic-loaded cement has a reported success rate of up to
82 % [4, 5], but is inferior to two-stage exchange, if it is
performed in a patient not qualifying for this procedure [6–9].
In aseptic stem revisions, uncemented stems have shown
reliable long-term results [10]. For PJI, uncemented
reimplantations are performed in two-stage exchanges [11,
12]. However, successful one-stage exchange with the use of
uncemented implants has also been described [13–15]. At our
hospital, an algorithm to stratify patients with established PJI
to the most appropriate management was developed in the
1990s. All patients in this series were treated accordingly [7,
16]. These treatment concepts were adopted in the recent
Infectious Diseases Society of America (IDSA) guide-
lines [6]. The different surgical treatment options are
debridement and implant retention, one-stage exchange,
two-stage exchange, resection arthroplasty or suppres-
sive therapy.
In this retrospective cohort study, we assessedwhether one-
stage exchange is a safe procedure in patients with PJI provid-
ed that they qualify according to the IDSA guidelines, except
for preoperative isolation of a microorganism [6].
Methods
All patients with infectious symptoms after hip replacement
(pain, local inflammation, fever) were evaluated for potential
PJI. Patient’s history and clinical findings were assessed, in-
cluding previous interventions, symptom duration, antibiotic
treatments and comorbidity. Standardised radiographs (pelvis
anteroposterior and false profile) were taken and compared
with all available previous radiographs to assess radiographic
stability and bone loss. Laboratory analyses included white
blood cell counts and C-reactive protein (CRP). In case of
fever, blood cultures were drawn. Preoperative joint aspiration
was routinely performed. Cell counts and differential of aspi-
rated synovial fluid was determined [17]. Tissue samples and/
or synovial fluid were incubated for a prolonged period
(2 weeks) to detect slow-growing microorganisms [18].
PJI was diagnosed according to IDSA guidelines. This def-
inition includes signs and symptoms of local infection plus at
least one of the following criteria: (1) growth of the same
microorganism in at least two cultures of synovial fluid,
periprosthetic tissue and/or sonication fluid; (2) visible pus
surrounding the joint without other explanation (e.g. no crys-
tals); or (3) acute inflammation on histopathological examina-
tion (>5 neutrophils/high-power field). All patients fulfilled
the modified criteria for one-stage exchange as defined by a
published algorithm and IDSA guidelines [6, 7]: intact soft
tissue (no sinus tract or abscess formation), susceptibility of
causative microorganisms to antibiotics with activity against
adhering pathogens (rifampin for staphylococci and
fluoroquinolones for Gram-negative bacilli) [19]. In 6/39 hips,
the microorganism was unknown at the time of surgery.
However, all qualified for the microbiological requirements
after surgery. These hips had low-grade infection and were
treated with vancomycin plus amoxicillin/clavulanic acid until
the microorganism and its susceptibility were known.
Revisions were performed via a transfemoral approach in
21 hips and a lateral approach in 18. At least four to six biop-
sies were taken intraoperatively for culture and histology to
confirm microbiological diagnosis, drug susceptibility and
signs of inflammation. Debridement consisted in thorough
removal of infected soft tissue, without bone resection. The
operative site was repeatedly manually rinsed with 0.2 %
polyhexanide solution (Lavasept®) with a syringe. Before re-
implantation, the surgeon’s gloves but not drapes or instru-
ments were changed.
Most acetabular reconstructions (29 hips) were performed
with a Müller acetabular reinforcement ring (Zimmer,
Winterthur, Switzerland), as the implant is proven to be reli-
able and is frequently used at our hospital. In case of major
defects (eight hips), we used a Burch Schneider antiprotrusio
cage (Zimmer) combined with a cemented Müller low-profile
polyethylene (PE) cup (Zimmer) [20]. Two reimplantations
were made with uncemented press-fit cups (Müller SL and
Allofit, both Zimmer). In the early cases, cemented stems
were preferably used in the more elderly patients; in 13 hips,
a cemented stem was implanted (12 Virtec, one CDH, both
Zimmer)—nine through a lateral approach. In later cases,
uncemented fixation was preferred. Twenty-six uncemented
stems were implanted (14 Wagner SL revision, 12 Revitan,
both Zimmer)—17 through a transfemoral approach, which
was preferred in case of extensive bone cement distal to the
tip of infected cemented stems and for uncemented stem fix-
ation. In 15 hips, morselised bone grafts were used to recon-
struct acetabular defects. Autologous (9), allogenous (2) and
combined (4) bone grafts were used. In case of cemented
fixation, standard gentamicin cement (Palacos R, later
Palacos R+G, Heraeus Medical, Wehrheim, Germany) was
used, irrespective of the susceptibility pattern of the microor-
ganism, using a second-generation cementing technique. No
additional antibiotics—either in cement or in bone grafts—
were administered. Up to four drains were used and remained
in place for 3–5 days. In case of imminent fluid retention after
drain removal, operative revision, including a second place-
ment of drains, was performed.
In 20 hips, antibiotic treatment was started after
arthrocentesis but before revision surgery. In the other 19 hips,
it was started intraoperatively either empirically or according
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to culture results from synovial fluid. It was continued intra-
venously for a minimum of 2 weeks. In staphylococcal infec-
tions, rifampin (450 mg twice daily per os) was added as soon
as the wound was dry. After 2 weeks, antibiotics were
switched to an oral regimen using drugs to which the infecting
agent was susceptible and had excellent bioavailability
(Table 1). The total duration of antibiotic treatment was
3 months. All complications and reoperations for any reason
were recorded.
All patients had a prospective clinical and radiological
follow-up during antibiotic therapy and after 1, 2 and 5 years.
Blood samples (blood cell counts, CRP) and standardised ra-
diographs were taken. Subsidence, osteolysis and radiolucent
lines were assessed. Functional results were documented with
a modified Harris Hip Score (HHS).
Results
From 1996 to 2011, 39 patients with 40 hips underwent one-
stage exchange due to PJI. One patient died 2 months after
revision surgery due to a carcinoma without any signs of per-
sistence of infection. Due to the short follow-up, this case was
excluded from the analysis. All others reached at least the 2-
year control, and no patient was lost to follow-up, which was a
mean of 6.6 years (2.0–15.1).
The mean duration of symptoms prior to revision surgery
was 9.7 months (1.2–33.2). Twenty of the 38 patients were
men; mean time after primary operation was 3.9 years (0.4–
16.5). Eight hips were previously revised for various reasons,
and one hip had previous surgery for infection (debridement
with implant retention for PJI), which had failed.
In a previous study, microbiological cure rates and func-
tional results of patients treated with implant exchange for
established PJI between 1985 and 2004 at our institution were
described [13]. Twenty of these hips with a one-stage proce-
dure were included in the study presented here.
In six hips, preoperative aspiration either revealed no fluid
or synovial culture was negative. None of these patients had a
history of previous antibiotic treatment. In these patients,
causative bacteria were identified in blood cultures or intraop-
erative tissue biopsies. In three hips, synovial fluid was posi-
tive, but additional bacteria [coagulase-negative staphylococci
(CNS) in all three cases} were detected from intraoperative
biopsy samples. Table 1 shows microbiology and antimicro-
bial therapy from each of the 39 hip revisions. CNS were the
most frequent pathogens (n=20), followed by streptococci
(n=9), Staphylococcus aureus (n=8), Gram-negative bacilli
(n=4), and Propionibacterium acnes (n=3). Five episodes
(12.5 %) were polymicrobial. In all patients undergoing em-
pirical therapy, antibiotics were streamlined as soon as the
susceptibility testing was available. In patients with staphylo-
coccal infection, the mean time between surgery and
administration of rifampin was 8 days (1–20). In six patients,
evacuation of fluid retention was required during index
hospitalisation, namely, 12–24 days after surgery. One patient
with dementia had recurrent dislocations, which were treated
with closed reduction. There were no other early
reinterventions. No patient had a relapse or a new infection,
and all were free of infection at the final follow-up visit. In
four hips, a stem revision was performed: one uncemented
stem 8 months after revision for early subsidence, and three
cemented stems for symptomatic aseptic loosening after 27,
34 and 59 months; all had a complete radiolucent line (Fig. 1).
In all four patients, microbiological healing was confirmed
with negative biopsy cultures at revision.
Besides the revised stem, no uncemented stem showed
subsidence >5mm. None of the ten unrevised cemented stems
had osteolysis or a complete radiolucent line, but six had an
incomplete radiolucent line mainly in the proximal third.
Mean HHS at the 2-year follow-up was 81 points (26–99).
Discussion
In PJI management, the most important aim is infection erad-
ication. In our series, infection was controlled in all 39 hips.
This excellent result was attained on the first attempt, except
in six patients in whom surgical evacuation of postoperative
fluid retention was performed during the index hospitalisation.
In 90 % of patients, the implant was still functional and in
place at the last follow-up visit. Four stems were replaced
because of loosening, which was not caused by low-grade
infection, as confirmed with negative intraoperative cultures.
All patients had a proven PJI that did not qualify for de-
bridement with implant retention [7]. In the same period of
time, 79 patients a a two-stage exchange, as they were not
appropriate for one-stage exchange [6]. In >80 % of cases,
the infecting agent and its susceptibility were known before
surgery. However, in six cases with suspected PJI, either
arthrocentesis was not performed, there was no synovial fluid
or synovia showed no bacterial growth (Table 1). In these
cases, PJI was confirmed with positive intraoperative biopsy
cultures. According to IDSA guidelines, these patients would
not qualify for one-stage exchange. However, Choi et al. [21]
showed that two-stage revision is not mandatory for all pa-
tients with no known preoperative microbiology.
Nevertheless, in patients with unknown microbiology, the risk
for failure is increased, since they may have PJI caused by
difficult-to-treat microorganisms, such as small-colony vari-
ants [22]. In our series, no patient without preoperative culture
results had a difficult-to-treat microorganism (Table 1).
Excellent treatment results in our study with a 100 % in-
fection cure rate may be because all patients had fair skin and
soft tissue, good bone stock and microorganisms susceptible
to an antibiotic with excellent bioavailability and efficacy on
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Antibiotic(s) IV Antibiotic(s) orally Antibiotic
pretreatment a
1 CNS CNS Cefazolin Ciprofloxacin/rifampin Yes
2 Enterobacter cloacae S aureus and
Enterobacter cloacae
Piperacillin/tazobactam Ciprofloxacin/rifampin Yes
3 CNS CNS Flucloxacillin Ciprofloxacin/rifampin Yes
4 No c CNS Flucloxacillin Ciprofloxacin/rifampin No
5 No c CNS Vancomycin/teicoplanin Ciprofloxacin/rifampin No
6 No c CNS Flucloxacillin Ciprofloxacin/rifampin No
7 Staphylococcus aureus S. aureus/CNS Flucloxacillin Ciprofloxacin/rifampin No
8 Streptococcus sanguis Streptococcus sanguis Penicillin Amoxicillin/rifampin No
9 CNS CNS Flucloxacillin Ciprofloxacin/rifampin Yes
10 S. aureus S. aureus Flucloxacillin Ciprofloxacin/rifampin Yes
11 CNS CNS Teicoplanin Fusidic acid/rifampin Yes
12 Escherichia coli E. coli Amoxicillin/clavulanic acid Ciprofloxacin Yes
13 Streptococcus agalactiae Streptococcus agalactiae Amoxicillin Amoxicillin Yes
14b S. aureus S. aureus Flucloxacillin Levofloxacin/rifampin Yes
15b S. aureus S. aureus Flucloxacillin Levofloxacin/rifampin Yes
16 Viridans streptococci Viridans streptococci Penicillin Levofloxacin/rifampin Yes
17 CNS CNS Flucloxacillin Levofloxacin/rifampin No
18 Streptococcus milleri Streptococcus milleri Penicillin Amoxicillin Yes
19 No d Anaerobic streptococci Amoxicillin/clavulanic acid Clindamycin/rifampin No
20 S. aureus S. aureus/CNS Teicoplanin Levofloxacin/rifampin Yes
21 No d P. acnes/CNS Penicillin Clindamycin/rifampin No
22 CNS CNS Vancomycin Levofloxacin/rifampin No
23 CNS CNS mycin Minocycline No
24 CNS CNS Vancomycin Fusidic acid/rifampin Yes
25 CNS CNS Vancomycin Fusidic acid/rifampin No
26 Streptococcus mitis Streptococcus mitis Penicillin Amoxicillin/rifampin Yes
27 Viridans streptococci Viridans streptococci Vancomycin Fusidic acid/rifampin No
28 Viridans streptococci Viridans streptococci Penicillin Amoxicillin/rifampin No
29 E. coli CNS Ceftriaxon Ciprofloxacin No
30 No c E coli Vancomycin/
Amoxicillin/clavulanic acid
Ciprofloxacin No
31 E. coli E. coli Ceftriaxon Ciprofloxacin No
32 S aureus S aureus Flucloxacillin Levofloxacin/rifampin Yes
33 S aureus S aureus Penicillin Levofloxacin/rifampin Yes
34 CNS CNS Vancomycin Fusidic acid/rifampin No
35 CNS CNS Vancomycin Fusidic acid/rifampin Yes
36 CNS CNS Vancomycin Minocycline/rifampin Yes
37 CNS and P. acnes CNS and Propionibacterium
acnes
Penicillin Clindamycin/rifampin No
38 Streptococcus mitis Streptococcus mitis Penicillin Cefuroxime Yes
39 P. acnes P. acnes Amoxicillin/clavulanic acid Clindamycin/rifampin No
CNS coagulase-negative staphylococci
a Antibiotic pretreatment after arthrocentesis, before one-stage exchange
b Same patient treated on both sides
c Arthrocentesis without fluid aspiration
d No growth in synovial fluid
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biofilm bacteria. Cases with identified difficult-to-treat bacte-
ria were stratified for two-stage procedures [22, 23], as were
all cases with severe soft-tissue destruction, since the risk for
failure with direct exchange is increased in these patients. In
staphylococcal infections, a rifampin-containing regimen, and
in Gram-negative infections, fluoroquinolone, was adminis-
tered [19]. Rifampin treatment was delayed until the wound
was dry in order to avoid emergence of resistance [24].
Preservation of function is the second most important aim
in treating patients with PJI. However, only limited data are
reported regarding joint function after treatment of infected
hip arthroplasty [13]. The extent of surgical debridement is
difficult to quantify; however, a strategy with direct exchange,
including radical debridement, of any tissue disregarding pos-
sible loss of function should be avoided [5]. Our aim was to
preserve functionally important structures and to perform
moderate debridement excluding extensive bone and soft-
tissue resection. As previously shown, HHS in patients with
one-stage exchange for PJI is comparable with that in patients
treated with revision for aseptic loosening and similar to that is
a series of primary implantations [13].
For reimplantation, we used the same established implant
systems, with documented long-term results, as we used in the
routine for aseptic loosening [10]. In our case series, three of
13 cemented stems failed due to symptomatic aseptic loosen-
ing after a mean of 40 months. Thus, uncemented reimplan-
tation might be the method of choice even in case of infection
[11, 25]. On the acetabular site, we mainly used reinforcement
rings due to modular options for restoring the hip centre; there
were no re-revisions for cup loosening. Other uncemented
revision cups might be used as well. With the described strat-
egy, a long-lasting fixation was achieved, which did not differ
from revision operations without infection [20].
Drains were used to avoid dead spaces and to dry out the
wound as soon as possible, which was a prerequisite for
starting rifampin therapy [24]. For that reason, fluid retention
was surgically removed in six patients. As no local antibiotics
were administered, this should not affect the concentration of
antibiotics in the operative field.
Standard gentamicin-loaded bone cement was used to fix the
cup in the rings and the cemented stems. In 26 hips with
uncemented femoral components, the use of cement was limit-
ed to PE cup fixation in the acetabular ring. It might be debated
that local antibiotic release contributed to curing the infection.
A limitation of our observational cohort study is the ab-
sence of a control group. For stratification to a one-stage ex-
change, we used criteria based on a well-established algorithm
and IDSA guidelines, except for preoperative knowledge of
the microorganism [6, 7]. Since patients without synovial fluid
(punctio sicca) or with negative preoperative culture without
synovial cell counts in favour of infection [6] could also have
aseptic loosening, one-stage exchange is indicated. In view of
these treatment guidelines, we consider randomisation to dif-
ferent treatment strategies as nonethical, since each patient
should be treated with the least invasive procedure for which
he or she qualifies [7]. Therefore, randomisation in two groups
with one- or two-stage procedures could hardly be justified.
The strength of our study is the standardised inclusion ac-
cording to accepted criteria [6, 7], the prospective acquisition
of standardised data in a cohort database and management of
each patient with a dedicated specialised team. In addition,
reporting the use of uncemented stems for one-stage revision
in patients with PJI adds new knowledge. It illustrates that
local antibiotics are not indispensable for infection elimination
during direct exchange. However, this observation must be
confirmed in larger studies.
Fig. 1 A 78-year-old male patient with primary hip replacement due to
osteoarthritis. He developed symptoms over a period of 4 months. Ten
months postoperatively, periprosthetic joint infection (PJI) was diag-
nosed, and puncture revealed Streptococcus sanguis. A one-stage
exchange was performed using a Müller reinforcement ring and a
cemented stem. The infection was treated with penicillin IV for 2 weeks
and amoxicillin/rifampin per os for 3 months. Over time, the patient
experienced lateral hip pain, and the stem was re-revised for aseptic
loosening. a) Anteroposterior (AP) radiograph before one-stage
exchange. b AP radiograph directly after one-stage exchange of both
components. c AP radiograph 34 months after one-stage exchange
showing a complete radiolucent line of the stem before re-revision
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In conclusion, one-stage revision is an attractive and safe
option for treating selected patients with PJI, and PJI can be
cured even without local administration of antibiotics.
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